Menu
Theme
Sign In(1) Biotechs have been taking good care of investors this year. (2) More FDA approvals help. (3) Drugs are increasingly more specialized, treating fewer people at higher prices. (4) T-cells on speed to the rescue. (5) Drug companies buying drugs. (6) Altering genes. (7) Pharmas lagging Biotechs. (8) Chinese fire drill for cryptocurrencies.
End of free preview
Ed's complete analysis, every chart linked, and the archive back to 2009.
Individual investor? Ed's QuickTakes are available for personal use at yardeniquicktakes.com →